119 related articles for article (PubMed ID: 11173905)
1. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis.
Ishizuka K; Sugimura K; Homma T; Matsuzawa J; Mochizuki T; Kobayashi M; Suzuki K; Otsuka K; Tashiro K; Yamaguchi O; Asakura H
Digestion; 2001; 63 Suppl 1():22-7. PubMed ID: 11173905
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
3. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
[TBL] [Abstract][Full Text] [Related]
4. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
5. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis.
Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS
Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144
[TBL] [Abstract][Full Text] [Related]
6. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
7. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis.
Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
Inflamm Res; 2004 Feb; 53(2):53-9. PubMed ID: 15021969
[TBL] [Abstract][Full Text] [Related]
8. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings.
Yamamoto T; Saniabadi AR; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2006 Aug; 12(8):719-26. PubMed ID: 16917227
[TBL] [Abstract][Full Text] [Related]
9. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
Ishiguro Y
J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
[TBL] [Abstract][Full Text] [Related]
10. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
[TBL] [Abstract][Full Text] [Related]
11. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
12. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease.
Meister D; Ghosh S
World J Gastroenterol; 2005 Dec; 11(47):7466-72. PubMed ID: 16437718
[TBL] [Abstract][Full Text] [Related]
13. A simple filter-paper technique allows detection of mucosal cytokine levels in vivo in ulcerative colitis. Interleukin-1 and interleukin-1-receptor antagonist.
Hendel J; Nielsen OH; Madsen S; Brynskov J
Dig Dis Sci; 1996 Sep; 41(9):1775-9. PubMed ID: 8794793
[TBL] [Abstract][Full Text] [Related]
14. [Influence of moxibustion with different duration on colonic epithelial structure, serum inflammatory cytokines, and intestinal mucosa inflammatory cell signal transduction pathways].
Ma TM; Han Y; Ma XD; Zeng XX; Ge W
Zhen Ci Yan Jiu; 2014 Feb; 39(1):20-6. PubMed ID: 24684107
[TBL] [Abstract][Full Text] [Related]
15. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
Gionchetti P; Campieri M; Belluzzi A; Tampieri M; Bertinelli E; Brignola C; Ferretti M; Boni P; Iannone P; Miglioli M
Agents Actions; 1992; Spec No():C50-2. PubMed ID: 1442335
[TBL] [Abstract][Full Text] [Related]
18. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease.
Bioque G; Crusius JB; Koutroubakis I; Bouma G; Kostense PJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1995 Nov; 102(2):379-83. PubMed ID: 7586694
[TBL] [Abstract][Full Text] [Related]
19. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
